Publicacións en colaboración con investigadores/as de University of Eastern Piedmont Amadeo Avogadro (22)

2022

  1. High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

    Frontiers in Oncology, Vol. 12

  2. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  3. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety

    Expert Review of Cardiovascular Therapy, Vol. 19, Núm. 4, pp. 325-335

  2. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320

  3. Spot-light on microbiota in obesity and cancer

    International Journal of Obesity, Vol. 45, Núm. 11, pp. 2291-2299

2020

  1. Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study

    Blood, Vol. 135, Núm. 5, pp. 381-386

  2. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983

  3. Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

    Leukemia

  4. Second cancers in MPN: Survival analysis from an international study

    American Journal of Hematology, Vol. 95, Núm. 3, pp. 295-301

2019

  1. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

    Leukemia, Vol. 33, Núm. 8, pp. 1996-2005

2017

  1. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

    Nature Communications, Vol. 8

  2. Overexpression of the cytokine BAFF and autoimmunity risk

    New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

    Leukemia Research, Vol. 39, Núm. 3, pp. 296-306

2014

  1. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3

2013

  1. Renal effects of levosimendan: A consensus report

    Cardiovascular Drugs and Therapy, Vol. 27, Núm. 6, pp. 581-590

2012

  1. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial

    JAMA, Vol. 307, Núm. 6, pp. 573-582

2009

  1. Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study

    Arthritis Research and Therapy, Vol. 11, Núm. 3

2008

  1. A treatment planning code for inverse planning and 3D optimization in hadrontherapy

    Computers in Biology and Medicine, Vol. 38, Núm. 9, pp. 990-999